Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
Abstract Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (ILD), driving its mortality. Specific biomarkers associated with the progression of this lung disease are highly needed. We aimed to identify specific biomarkers of SSc-ILD...
Saved in:
Main Authors: | Julien Guiot, Makon-Sébastien Njock, Béatrice André, Fanny Gester, Monique Henket, Dominique de Seny, Catherine Moermans, Michel G. Malaise, Renaud Louis |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/332d152eea1a43e2b6806c3da08770b0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
by: P. Jacquerie, et al.
Published: (2021) -
Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
by: Xinh-Xinh Nguyen, et al.
Published: (2021) -
Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
by: Gema Vallés, et al.
Published: (2021) -
Cognitive dysfunction in pediatric multiple sclerosis
by: Suppiej A, et al.
Published: (2014) -
Association of IGFBP3 Gene (rs2854744) Polymorphism and Colorectal Cancer
by: M Arkani, et al.
Published: (2012)